These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31668819)

  • 1. Factors associated with the willingness of primary caregivers to avail of a dengue vaccine for their 9 to 14-year-olds in an urban community in the Philippines.
    Reyes MSGL; Lee KMG; Pedron AML; Pimentel JMT; Pinlac PAV
    Vaccine; 2020 Jan; 38(1):54-62. PubMed ID: 31668819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability of the dengue vaccination among parents in urban poor communities of Quezon City, Philippines before and after vaccine suspension.
    Valido EM; Laksanawati IS; Utarini A
    BMC Res Notes; 2018 Sep; 11(1):661. PubMed ID: 30201034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay for a dengue vaccine and its associated determinants in Indonesia: A community-based, cross-sectional survey in Aceh.
    Harapan H; Anwar S; Bustamam A; Radiansyah A; Angraini P; Fasli R; Salwiyadi S; Bastian RA; Oktiviyari A; Akmal I; Iqbalamin M; Adil J; Henrizal F; Darmayanti D; Mahmuda M; Mudatsir M; Imrie A; Sasmono RT; Kuch U; Shkedy Z; Pramana S
    Acta Trop; 2017 Feb; 166():249-256. PubMed ID: 27908746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue vaccine acceptance and associated factors in Indonesia: A community-based cross-sectional survey in Aceh.
    Harapan H; Anwar S; Setiawan AM; Sasmono RT;
    Vaccine; 2016 Jul; 34(32):3670-5. PubMed ID: 27208588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The demand for a dengue vaccine: a contingent valuation survey in Metro Manila.
    Palanca-Tan R
    Vaccine; 2008 Feb; 26(7):914-23. PubMed ID: 18206277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of felt demand for dengue vaccines in the North Caribbean region of Colombia.
    Bracho-Churio YT; Martínez-Vega RA; Rodriguez-Morales AJ; Díaz-Quijano RG; Luna-González ML; Diaz-Quijano FA
    Ann Clin Microbiol Antimicrob; 2017 May; 16(1):38. PubMed ID: 28506229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DENGUE PREVENTION: CONFIRMATORY FACTOR ANALYSIS OF RELATIONSHIPS BETWEEN ECONOMIC STATUS, KNOWLEDGE, ATTITUDES AND PRACTICE, VACCINE ACCEPTANCE AND WILLINGNESS TO PARTICIPATE IN A STUDY.
    Harapan H; Bustamam A; Radiansyah A; Angraini P; Fasli R; Salwiyadi S; Bastian RA; Oktiviyari A; Akmal I; Iqbalamin M; Adil J; Henrizal F; Groneberg DA; Kuch U; Muller R
    Southeast Asian J Trop Med Public Health; 2017 Mar; 48(2):297-305. PubMed ID: 29641880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue vaccine acceptance and willingness to pay.
    Harapan H; Fajar JK; Sasmono RT; Kuch U
    Hum Vaccin Immunother; 2017 Apr; 13(4):786-790. PubMed ID: 27905832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines.
    Capeding RZ; Luna IA; Bomasang E; Lupisan S; Lang J; Forrat R; Wartel A; Crevat D
    Vaccine; 2011 May; 29(22):3863-72. PubMed ID: 21477675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caregivers' Willingness to Accept Expedited Vaccine Research During the COVID-19 Pandemic: A Cross-sectional Survey.
    Goldman RD; Marneni SR; Seiler M; Brown JC; Klein EJ; Cotanda CP; Gelernter R; Yan TD; Hoeffe J; Davis AL; Griffiths MA; Hall JE; Gualco G; Mater A; Manzano S; Thompson GC; Ahmed S; Ali S; Shimizu N;
    Clin Ther; 2020 Nov; 42(11):2124-2133. PubMed ID: 33067013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial.
    Biswal S; Borja-Tabora C; Martinez Vargas L; Velásquez H; Theresa Alera M; Sierra V; Johana Rodriguez-Arenales E; Yu D; Wickramasinghe VP; Duarte Moreira E; Fernando AD; Gunasekera D; Kosalaraksa P; Espinoza F; López-Medina E; Bravo L; Tuboi S; Hutagalung Y; Garbes P; Escudero I; Rauscher M; Bizjajeva S; LeFevre I; Borkowski A; Saez-Llorens X; Wallace D;
    Lancet; 2020 May; 395(10234):1423-1433. PubMed ID: 32197105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine Demand and Willingness-to-pay for Arbovirus Vaccines: A Cross-sectional Survey in Rural Guatemala.
    Olson D; Rick AM; Krager S; Lamb M; Asturias EJ
    Pediatr Infect Dis J; 2018 Nov; 37(11):1184-1189. PubMed ID: 30153226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting vaccine hesitancy among families with children 2 years old and younger in two urban communities in Manila, Philippines.
    Migriño J; Gayados B; Birol KRJ; De Jesus L; Lopez CW; Mercado WC; Tolosa JC; Torreda J; Tulagan G
    Western Pac Surveill Response J; 2020; 11(2):20-26. PubMed ID: 33537161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue Dynamics and Vaccine Cost-Effectiveness Analysis in the Philippines.
    Shim E
    Am J Trop Med Hyg; 2016 Nov; 95(5):1137-1147. PubMed ID: 27601519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial.
    Tricou V; Sáez-Llorens X; Yu D; Rivera L; Jimeno J; Villarreal AC; Dato E; Saldaña de Suman O; Montenegro N; DeAntonio R; Mazara S; Vargas M; Mendoza D; Rauscher M; Brose M; Lefevre I; Tuboi S; Borkowski A; Wallace D
    Lancet; 2020 May; 395(10234):1434-1443. PubMed ID: 32197107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in Bandung, Indonesia.
    Hadisoemarto PF; Castro MC
    PLoS Negl Trop Dis; 2013; 7(9):e2427. PubMed ID: 24069482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: A case-control study.
    Ylade M; Agrupis KA; Daag JV; Crisostomo MV; Tabuco MO; Sy AK; Nealon J; Macina D; Sarol J; Deen J; Lopez AL
    Vaccine; 2021 Aug; 39(37):5318-5325. PubMed ID: 34373121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, Attitude, and Practices Regarding Dengue Fever among Pediatric and Adult In-Patients in Metro Manila, Philippines.
    Herbuela VRDM; de Guzman FS; Sobrepeña GD; Claudio ABF; Tomas ACV; Arriola-Delos Reyes CM; Regalado RA; Teodoro MM; Watanabe K
    Int J Environ Res Public Health; 2019 Nov; 16(23):. PubMed ID: 31779171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness and influential factors of parents to vaccinate their children with novel inactivated enterovirus 71 vaccines in Guangzhou, China.
    Li T; Wang H; Lu Y; Li Q; Chen C; Wang D; Li M; Li Y; Lu J; Chen Z; Ma Y; Liu W; Ma M; Wu D; Lu J; Yang Z
    Vaccine; 2018 Jun; 36(26):3772-3778. PubMed ID: 29776754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.
    Capeding MR; Tran NH; Hadinegoro SR; Ismail HI; Chotpitayasunondh T; Chua MN; Luong CQ; Rusmil K; Wirawan DN; Nallusamy R; Pitisuttithum P; Thisyakorn U; Yoon IK; van der Vliet D; Langevin E; Laot T; Hutagalung Y; Frago C; Boaz M; Wartel TA; Tornieporth NG; Saville M; Bouckenooghe A;
    Lancet; 2014 Oct; 384(9951):1358-65. PubMed ID: 25018116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.